News stories
2009
Caring for diabetes: Live webcast Tuesday, April 28
Studies show that people with psoriasis have an increased risk of developing diabetes. Tune in to a live webcast featuring Dr. Tom Elasy who will discuss the disease.
– April 21, 2009
National Psoriasis Foundation statement on Genentech withdrawing Raptiva
The National Psoriasis Foundation recommends patients currently using Raptiva (efalizumab) to immediately contact their dermatologist and find an alternative treatment option
– April 8, 2009
National Psoriasis Foundation launches new mission statement
Today, the National Psoriasis Foundation launched a new mission statement: To find a cure for psoriasis and psoriatic arthritis and to eliminate their devastating effects through research, advocacy and education.
– March 4, 2009
Raptiva may cause serious side effects
Patients taking the drug Raptiva, a treatment for moderate to severe psoriasis, may be at risk for developing progressive multifocal leukoencephalopathy (PML) a rare, but usually fatal virus that attacks the brain.
– Feb. 24, 2009
Ustekinumab improves psoriatic arthritis, study says
The new biologic drug ustekinumab, which is expected to be approved later this year to treat psoriasis, significantly improves the symptoms of psoriatic arthritis, according to a study published in the Feb. 12, 2009, online issue of The Lancet medical journal.
– Feb. 17, 2009
National Psoriasis Foundation sheds light on barriers to care
Sheila Rittenberg, senior director of advocacy and external affairs for National Psoriasis Foundation, submitted a letter to the editor in response to a February 4 article in the Charleston Daily Mail.
– Feb. 5, 2009
National Psoriasis Foundation submits letter to President Obama
The National Psoriasis Foundation sent a letter to President Barack Obama asking for reform of harmful and discriminatory health insurance practices, especially those that affect the millions of Americans living with psoriasis and psoriatic arthritis.
– Jan. 29, 2009
Erythrodermic Psoriasis - Live Webcast
Erythrodermic psoriasis, a particularly inflammatory form of the skin disease, its symptoms, complications and potential causes will be discussed during a live webcast at noon (CST) Tuesday, Feb. 3.
– Jan. 28, 2009
Psoriasis Foundation official meets with influential congressional leader
Rick Seiden, vice chairman of the National Psoriasis Foundation's Board of Trustees, met recently with Rep. Henry Waxman (D-Calif.-30th) to discuss the challenges of living with psoriasis and psoriatic arthritis.
– Jan. 5, 2009
Archives
2008 news stories
Older archives